Stay updated on Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial
Sign up to get notified when there's something new on the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page.

Latest updates to the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the usual study content. This indicates access to the study record is blocked rather than an update to its information.SummaryDifference16%

- Check45 days agoChange DetectedThe page now includes 2019 (U.S. NIH Grant/Contract) as part of the study's external identifiers. The page revision was updated to v3.6.6 (replacing the previous v3.6.5).SummaryDifference0.0%

- Check66 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5. This indicates a minor documentation update on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedZaporizhzhya, Ukraine has been added to the study locations, and Zaporizhzhia, Ukraine has been removed from the list. This reflects a transliteration update for the city's name in the locations data.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page’s revision marker was updated from v3.6.3 to v3.6.4, signaling a small system or documentation update without changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page.